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Shigella invasion into the colonic epithelium involves many
steps including the formation of largemembrane protrusions by
the epithelial cells that facilitate bacterial engulfment. IpaA, a
Shigella protein secreted into target cells upon cell contact
induces a loss of actin stress fibers in cells and promotes the
reorganization of actin at the site of entry. The mechanism for
this is not known but is thought to involve recruitment of the
focal adhesion protein vinculin to IpaA.Here we have examined
themechanism for the effects of IpaA on the actin cytoskeleton.
We show that IpaA-induced loss of actin stress fibers and cell
rounding do not require vinculin expression or an intact vincu-
lin binding site on IpaA. Rather, we find that cells expressing
IpaA exhibited elevated Rho activity and increasedmyosin light
chain phosphorylation. In addition, IpaA decreases integrin
affinity for extracellular matrix ligands by interfering with talin
recruitment to the integrin cytoplasmic tail. The combination of
these two effects, namely weakened adhesion and increased
contractility, account for the loss of actin stress fibers and cell
rounding observed in cells exposed to IpaA.
Shigella, the causative agent of bacillary dysentery, is aGram-
negative bacterium that exerts its effects by invading the
colonic mucosa. Upon entry into the epithelium of the colon,
Shigellamultiply, cause cell death, and spread laterally to infect
and kill adjacent epithelial cells, inducing ulceration, inflamma-
tion, and bleeding. To facilitate entry, Shigella triggers de novo
actin polymerization that drives the formation of large mem-
brane protrusions that arise from the epithelium and evolve
into a phagocytic-like cup that merges above the bacterium.
These protrusions are rich in densely branched actin networks
that are reorganized to allow for closure of the phagocytic cup
and internalization of the bacterium. Elucidation of the molec-
ular bases of these cytoskeletal rearrangements is essential for
better understanding the mechanism of Shigella entry.
To facilitate invasion, the Shigella type III secretion sys-
tem is stimulated upon contact with host cells and delivers
bacterial “effector” molecules into the surrounding bacterial
space and/or host cell membrane (1). These invasins directly
alter the host cell cytoskeleton and/or allow for the delivery
of other type III effectors into the cytoplasm to promote
invasion. For Shigella, these invasins include IpaA, IpaB, IpaC,
IpaD, IpgD, IpgB, andVirA (2) and are reviewed inRefs. 3 and 4.
Among these, the Ipa proteins are essential for entry (5). Shi-
gellamutants unable to express IpaB, IpaC, or IpaD are not able
to invade epithelial cells and IpaAmutants are impaired 10-fold
(6–8). Exploring the molecular basis for how Ipa proteins alter
the host cell cytoskeleton revealed that IpaB, IpaC, and IpaD
elicit actin rearrangements at the site of bacterial attachment
that are required for entry, whereas IpaA may promote the
reorganization of these actin-rich structures (8).
One target of the Ipa proteins aremembers of the Rho family
of GTPases (9, 10). Rho proteins act as molecular switches
cycling between an active GTP-bound form and inactive GDP-
bound state. Active Cdc42 and Rac trigger activation of the
Arp2/3 complex and the formation of filopodia and lamellipo-
dia, respectively (reviewed in Ref. 11). IpaC induces changes in
the actin cytoskeleton, characteristic of active Cdc42 and Rac,
and this effect is blocked by dominant negative versions of
Cdc42 or Rac, or the Cdc42-binding domain ofWASP suggest-
ing that IpaC may up-regulate the activity of these GTPases
(12). The mechanism for this is likely to involve phosphoryla-
tion of Crk by Abl tyrosine kinases and the subsequent activa-
tion of PAK (13, 14). Like Cdc42 and Rac, Rho activity is
required for Shigella entry (9, 15). Increases in Rho activity
stimulate numerous Rho effectors that could potentially
remodel the actin cytoskeleton and drive increased contractil-
ity. For example, the RhoA effector Rho kinase increases phos-
phorylation of themyosin II regulatory light chain both directly
and indirectly by inhibition of themyosin phosphatase (16, 17).
The mechanism of Rho activation at the site of Shigella entry is
unknown, but its activity is essential for the remodeling of the
actin cytoskeleton and folding of membranes that occurs at the
site of entry (9).
Another group of proteins that are localized to the site of
bacterial entry and targeted by the Shigella effectors are adhe-
sion receptors. IpaB binds to the extracellular domain of CD44,
a transmembrane receptor that interacts with hyaluronic acid,
and promotes Shigella entry (18, 19). Integrins are transmem-
brane adhesion receptors consisting of  and  subunits that
serve as links between the extracellular matrix on the outside
and the cytoskeleton on the inside. They are highly enriched at
sites of bacterial entry and their expression level positively cor-
relates with Shigella invasiveness (20). A complex of IpaB and
IpaCbind to integrins (20) andmay allow for transient adhesion
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of the bacterium with the cell surface to promote internaliza-
tion (20). IpaA binds to vinculin, a protein present at the cyto-
plasmic face of integrins (8). The interaction of IpaA with vin-
culin increases recruitment of F-actin to vinculin (21, 22). A
complex of vinculin and IpaA was shown to reduce F-actin
sedimentation and decrease filament assembly on an EM grid
leading the authors to suggest that this complex is important
for “depolymerization” of actin filaments at the site of Shigella
entry (21).
Here we explore how IpaA promotes the cytoskeletal rear-
rangements necessary for bacterial entry. We provide evidence
that there is a loss of stress fibers in vinculin-nullmouse embryo
fibroblasts (MEFs)2 expressing IpaAor in fibroblasts expressing
a mutant of IpaA unable to bind vinculin. We find that cells
expressing IpaA have elevated Rho activity and increased phos-
phorylation of myosin light chain resulting in increases in con-
tractility that can be blocked by inhibitors of Rho kinase. Fur-
thermore, we show that IpaA negatively regulates cell-matrix
adhesion by interfering with recruitment of talin to the integrin
cytoplasmic tail. The combination of IpaA-induced de-adhe-
sion and increased contractility account for the loss of actin
stress fibers and cell rounding observed in cells exposed to
IpaA.
EXPERIMENTAL PROCEDURES
Reagents and Cell Lines—The vinculin-null mouse embryo
fibroblasts (Vin/; Ref. 23) were a generous gift of E. Adamson
(Burnham Institute, La Jolla, CA). Vin/, HeLa, and REF52s
were maintained in Dulbecco’s modified Eagle’s medium 
10% fetal bovine serum as previously described (24). Human
fibronectin was prepared as previously described (25). For the
Rho kinase inhibitor studies, Y27632 (Calbiochem) was resus-
pended inMe2SO, diluted to a final concentration of 750 nM in
growth media for 30 min prior to and during microinjection.
Constructs—The GFP, Myc, and GST fusion proteins were
constructed by PCR amplification of a cDNA of interest from
pEC15 (26). Full-length IpaA was cloned using GGATCCAT-
GCATAATGTAATAATACTCAAGCGCCAACATTC as the
upstream primer and GAATTCTTAATCCTTATTGATAT-
TCTTTAATACTTTTGATAGGG as the downstream primer.
IpaA-(1–500) was constructed using the full-length upstream
primer and GAATTCGGAGTTTGTTACTTTTTTTGAAGC
as the reverse primer and IpaA-(500–633) was constructed
using GGATCCGGAACACAAGAACGAGAGTTACAGG as
the forward primer and the full-length IpaA downstream
primer. The resulting PCR products were cloned into the BglII-
EcoRI sites of pEGFP-C1, or the BamHI-EcoRI sites of pGEX-T
(Amersham Biosciences) or pCMV6, an amino-terminal Myc
epitope-tagged eukaryotic expression vector (gift of Dr.
Jonathan Chernoff, Fox Chase Cancer Center).
Rho Activity—Rho activity assays were performed as previ-
ously described (27) using the RhoA-binding domain of Rho-
tekin expressed as a GST fusion protein. The cDNA of the
RhoA-binding domain (RBD) of Rhotekin comprising amino
acids 7–89 was cloned into the pGEX-2T vector and expressed
as a GST fusion protein. REF52 cells expressing GFP, GFP-
IpaA, GFP-IpaA-(1–500), or GFP-IpaA-(500–633) were
washed twice inHEPES-buffered saline and lysed in 50mMTris,
pH 7.6, 150mMNaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1%
Triton X-100, and 10 mM MgCl2. Thirty micrograms of GST-
RBD attached to glutathione-Sepharose beads were incubated
with clarified lysates for 30min at 4 °C. The beads were washed
four times in lysis buffer and the resulting products were ana-
lyzed using SDS-PAGE.
Immunoprecipitation andWestern Blot Analysis—Cells were
washed in HBS (20 mM HEPES, pH 7.4, 150 mM NaCl  2 mM
Na3VO4, and lysed in ice-cold EB (1% Triton X-100, 10 mM
Tris, pH 7.4, 5 mM EDTA, 50 mM NaCl, 50 mM NaF, 20 g/ml
aprotinin, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml leu-
peptin, and 2 mM Na3VO4). Immunoprecipitation and immu-
noblotting were performed as previously described (24) using
the following commercially available anti-sera: GFP (Roche
and Clontech), Rho (BD Transduction Labs), phospho-Ser19
myosin light chain (BIOSOURCE), and myosin light chain
(My-21; Sigma). Vinculin (G989) or talin (N681) were immu-
noblotted and immunoprecipitated with polyclonal antibod-
ies raised against the full-length proteins as previously
described (24, 28).
Immunofluorescence—Cells were fixed in 3.7% formaldehyde
in phosphate-buffered saline, permeabilized in 0.5% Triton
X-100, and washed in TBS (150 mM NaCl, 50 mM Tris, pH 7.6,
0.1%NaN3). To visualize actin, cells were incubated with Texas
Red-conjugated phalloidin (Molecular Probes) at 1:200 for 1 h
at 37 °C, washed in universal buffer, and mounted on glass
slides. Images were obtained as previously described using a
Zeiss axiovert microscope. Images were acquired with a
Hamamatsu ORCA-ER cooled charge-coupled device camera
(Zeiss) and processed using Metamorph Image software (Uni-
versal Imaging). Vinculin was visualized using hVIN-1 (Sigma)
at 1:400 followed by an anti-mouse Alexa 488-conjugated sec-
ondary antibody.
Microinjection—Cells were seeded onto glass bottom dishes
(MATEK) 24 h prior to microinjection in Dulbecco’s modified
Eagle’s medium  10% fetal bovine serum. The dishes of cells
were moved to a 37 °C incubation chamber for imaging. GST-
IpaA was harvested from BL21(DE3) cells expressing a chaper-
one plasmid (TakaraMirus Bio) to facilitate recovery of soluble
plasmid cultures induced with 0.33 mM isopropyl 1-thio--D-
galactopyranoside overnight at room temperature. Bacterial
cells were lysed, sonicated, and GST-IpaA was purified using
glutathione-Sepharose beads. The purified products were con-
centrated using a microconcentrator and dialyzed into micro-
injection buffer (25mMTris, pH 7.3, 100mMKCl, 5 mMMgCl2,
1 mM EGTA), and injected at a concentration of 20 g/ml. The
cells were monitored for 30 min using Zeiss axiovert inverted
microscope equipped with a heat and humidified chamber and
a Hamamatsu ORCA ER camera. Images were acquired as
described above.
In Vitro Binding to Integrin Cytoplasmic Domain Constructs—
The synthetic 1A integrin cytoplasmic binding was obtained
from Mark Ginsberg and purified as previously described (29).
Platelet extracts were prepared as previously described (30). The
2 The abbreviations used are: MEF, mouse embryo fibroblasts; GFP, green
fluorescent protein; RBD, RhoA-binding domain; FACS, fluorescence-acti-
vated cell sorter.
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platelet extracts were passed over a DEAE-52 column and the
five column fractions most enriched for talin were pooled. The
pH of these samples was adjusted to 7.5 and the salt concentra-
tion was adjusted to 50 mM. Nickel-nitrilotriacetic acid beads
containing 50 g of purified 1a integrin cytoplasmic domain
were incubatedwith 300l of talin-enriched platelet extracts in
the presence of 0.2 or 2 g of GST or GST-IpaA. The resulting
beads were washed four times in ice-cold phosphate-buffered
saline 0.5%TritonX-100, reconstituted in sample buffer, and
subjected to Western blot analysis.
FACSAnalysis—Subconfluent cultures ofHeLa cells expressing
Myc or Myc-IpaA were lifted from tissue culture dishes by incu-
bation in phosphate-buffered saline 0.6mMEDTA for 15min
at 37 °C, washed, and stainedwith TS2/16 (American Type Tis-
sue Culture Collection) or 12G10 (Chemicon) for 1 h at 4 °C.
The cells were washed two times, stained with an anti-mouse
IgG antibody conjugated with fluorescein (Chemicon) for 30
min at 4 °C, and washed three additional times. The stained
cells were resuspended in Dulbecco’s modified Eagle’s medium
 0.2% fetal bovine serum, and analyzed in the University of
North Carolina flow cytometry facility. For each wash step the
cells were resuspended and pelleted in Dulbecco’s modified
Eagle’s medium  0.2% fetal bovine serum.
RESULTS
Upon contact with a host cell, Shigella triggers the formation
of large membrane protrusions that arise from the host cell
surface and engulf the bacterium. To form a structure that is
productive for entry these densely packed actin-richmembrane
protrusions reorganize. Both Rho and a complex of IpaA and
vinculin have been implicated in the actin cytoskeletal rear-
rangements that occur during Shigella entry (9, 21). However,
the mechanisms remain elusive. To investigate how IpaA
affects the actin cytoskeleton, we cloned IpaA and studied the
effects of recombinant IpaA expressed as a fusion with GFP in
mammalian cells. We assessed whether our recombinant IpaA
exhibited the same characteristics as IpaA purified from bacte-
rial supernatants (21). For this, we examined coprecipitation of
vinculin with GFP or GFP-IpaA immunoprecipitated from
HeLa cell lysates. Consistently we immunoprecipitated much
more GFP than GFP-IpaA from cell lysates but always detected
vinculin binding only to GFP-IpaA and not to GFP alone (Fig.
1A). Previous findings suggested that IpaA purified from bac-
terial supernatants induced a loss of stress fibers when micro-
injected into cells (21). We examined whether our GFP-IpaA
was able to have a similar effect when transiently expressed. For
these studies we utilized the REF52 cell line, which unlike HeLa
cells, form robust actin stress fibers that are easily visualized.
Under these conditions, 90  5% of GFP-expressing cells
formed large actin stress fibers that were easily visualized and
indistinguishable from the untransfected cells (Fig. 1B). In con-
trast, 31  7% of the cells expressing GFP-IpaA had no detect-
able stress fibers and 20  9% of the cells showed a partial
decrease in the number of actin stress fibers (Fig. 1C).
It was a bit surprising that such a large number of cells (i.e.
49  2%) would have relatively intact stress fibers. Sites
where stress fibers terminate are known as focal adhesions.
We considered whether disassembling the preexisting focal
FIGURE 1. Recombinant IpaA binds to vinculin and induces a loss of actin
stress fibers. A, recruitment of GFP-IpaA to vinculin. HeLa cells were tran-
siently transfected with GFP or GFP-IpaA, allowed to recover for 18 h, lysed,
and the fusion proteins were immunoprecipitated using an antibody against
GFP. The resulting immunoprecipitates were subjected to Western blot anal-
ysis with antibodies against vinculin or GFP. Note the lower molecular weight
band in the IpaA lane appears to an incompletely transcribed product of GFP-
IpaA. B–D, overexpression of GFP-IpaA induces a loss of actin stress fibers.
REF52 cells transfected with GFP (B) or GFP-IpaA (C) were fixed, stained, and pro-
cessed for fluorescence microscopy 18 h post-transfection, or D, trypsinized and
replated on fibronectin-coated coverslips for 4 h. Right panels show GFP fluo-
rescence and left panels were stained with rhodamine-conjugated phal-
loidin. Transfected cells were scored for a loss of stress fibers. The percent-
age of cells having no detectable actin stress fibers (absent), partial stress
fibers (partial), or no loss of stress fibers (no effect) are indicated in the top
right corner of each image. A cell was scored as having partial stress fibers if
it had five or more visible stress fibers. Data are expressed as the mean  S.D.
of three independent experiments. Bar  50 m. FITC, fluorescein
isothiocyanate.
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adhesions might allow IpaA to access these sites better and
have a greater effect. To test this possibility, focal adhesions
were disassembled by resuspending cells by trypsinization fol-
lowed by replating on fibronectin-coated coverslips for 4 h.
Under these conditions, the percentage of IpaA-expressing
cells lacking stress fibers significantly increased to 93  7%,
whereas replating had relatively no effect on the stress fibers in
GFP-expressing cells (Fig. 1D). Taken together, these results
suggest that expression of recombinant IpaA induces a loss of
actin stress fibers to a similar extent as microinjection of IpaA
purified from bacterial supernatants.
Vinculin Is Not Required for the Effects of IpaA on the Actin
Cytoskeleton—Earlier work implicated vinculin recruitment to
IpaA as key for the loss of stress fibers and cell rounding
observed in cells exposed to IpaA (21). To test the requirement
for vinculin, we assessed the morphology and the integrity of
actin stress fibers in vinculin-null (Vin/) MEFs expressing
GFP-IpaA or GFP alone (31). Surprisingly, the vinculin-null
cells expressing GFP-IpaA showed a marked decrease in the
number of stress fibers and were more rounded as compared
with the GFP-expressing or untransfected control Vin/
MEFs (Fig. 2A) suggesting that vinculin is not required for the
effect on stress fibers by IpaA. IpaA had a slightly greater effect
on stress fibers in theVin/MEFs than in the REF52s, because
58  13% of cells had no detectable actin stress fibers (Fig. 2B).
These findings were not the result of prolonged exposure to
IpaA because Vin/ MEFs microinjected with GST-IpaA
rounded very rapidly and did not appear to recover during the
first 15 min of exposure (supplemental data). In contrast GST-
injected cells were indistinguishable from the uninjected con-
trols (supplemental data).
It is possible that in the absence of vinculin, the MEFs up-
regulate a compensatory pathway that allows IpaA to induce a
loss of stress fibers. To further explore whether vinculin is
required for the effect of IpaA, we considered generating a
mutant of IpaA that could not bind vinculin. This would allow
us to examine the phenotype of the mutant IpaA when
expressed in the presence of vinculin in REF52 cells. We
mapped the vinculin binding site on IpaA using IpaA fragments
expressed as fusions with GFP (Fig. 3A). Several overlapping
fragments co-precipitated vinculin from cell lysates and identi-
fied the C-terminal 134 amino acids (residues 500–633) as the
critical domain (Fig. 3B). We next assessed the ability of GFP
fusions with either one of these two IpaA fragments to induce a
loss of stress fibers and cell rounding in REF52 cells (Fig. 3C) or
Vin/ MEFs (Fig. 2). In both cell lines, the fragment of IpaA
that bound vinculin (IpaA-(500–633)) behaved similarly to
GFP. Neither cell line exhibited a significant decrease in actin
stress fibers (Figs. 2 and 3C). In some instances the number and
intensity of stress fibers in the GFP-IpaA-(500–633) express-
ing cells appeared to be increased (Figs. 2A and 3C). In contrast,
cells exposed to the fragment of IpaA lacking the vinculin bind-
ing site (GFP-IpaA-(1–500)) behaved similarly to full-length
GFP-IpaA, and exhibited a noticeable decrease in the number
of actin stress fibers (Figs. 2 and 3C). Taken together these
results demonstrate that vinculin is not required for IpaA-in-
duced cytoskeletal rearrangements.
These findings led us to pursue alternative mechanisms for
how IpaA induces a loss of actin stress fibers. The small GTPase
Rho appeared as a likely candidate because inhibiting Rho leads
to a loss of stress fibers and focal adhesions. We measured Rho
activity in cells expressing GFP-IpaA. Contrary to what we
expected, we found that cells expressing GFP-IpaA had ele-
vated RhoGTP levels when compared with the GFP-expressing
cells (Fig. 4A). This effect could be mapped to the first 500
amino acid residues of IpaA because cells expressing GFP-
FIGURE 2. Vinculin is not required for the effects of IpaA. A, vinculin-null
MEFs expressing GFP, GFP-IpaA, GFP-IpaA-(1–500), or GFP-IpaA-(500 – 633)
were fixed, permeabilized, and stained with Texas Red-conjugated phalloidin
(actin, right panels). Representative images of the GFP fluorescence are shown
in the left panels. B, cells expressing GFP or the GFP-IpaA clone denoted and
exhibiting a complete loss (absent), partial decrease (partial), or wild-type
levels of stress fibers were quantitated and expressed as a percentage of total
cells.
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IpaA-(1–500), but not GFP-IpaA-(500–633), had high Rho
activity (Fig. 4A). One downstream effector of Rho is Rho
kinase, which promotes myosin light chain phosphorylation
thereby stimulating actomyosin contractility (16, 17). To deter-
mine whether increased contractility is a consequence of
increased Rho activity in cells expressing IpaA, we examined
myosin light chain phosphorylation in lysates harvested from
GFP or GFP-IpaA-expressing cells. In comparison to the GFP
control cells, myosin light chain phosphorylationwas increased
in lysates harvested fromGFP-IpaA or GFP-IpaA-(1–500) (Fig.
4B). The GFP-IpaA-(500–633) expressing cells showed no
change in the levels of phosphorylatedmyosin light chain when
compared with the GFP controls (Fig. 4B). Hence IpaA acti-
vates Rho and increases the phosphorylation of myosin light
chain independently of binding to vinculin.
If IpaA-induced cell rounding is the result of increased acto-
myosin contractility stimulated by elevated Rho activity, then
inhibiting this pathway should prevent cell rounding. To test
this, we incubated cells with a low dose of the Rho kinase inhib-
itor Y27632 that inhibits Rho kinase activity without inducing
gross structural changes in cell morphology. These cells were
microinjected with GST or GST-IpaA.We found that cells pre-
incubated with Y27632 and injected with GST-IpaA resembled
the GST-injected cells, in that they did not round during the
first 30min of exposure (supplemental Data B). This confirmed
that IpaA-dependent cell rounding is the result of Rho-medi-
ated increased contractility.
IpaA Induces the Disassembly of Focal Adhesions—Cells
expressingGFP-IpaA appeared lesswell spread, consistentwith
the idea that IpaA may be decreasing integrin-mediated cell
adhesion. To test this hypothesis, we used FACS analysis to
determine whether IpaA affects the affinity or amount of 1
integrin on the cell surface using the monoclonal antibodies
12G10 and TS216 (32). Myc-IpaA-expressing cells showed a
marked decrease in active integrins on the cell surface as com-
pared with the Myc only expressing cells (Fig. 5A). The total
levels of integrin on the cell surface were not altered in the two
cell types (Fig. 5B) suggesting that IpaA induces de-adhesion by
decreasing integrin affinity for its ligands.
Control of integrin affinity for ligands is regulated by talin
recruitment to the cytoplasmic domain (33). This triggers con-
formational changes in the integrin associated with a conver-
sion from a low to a high affinity for ligands (34) and the subse-
quent recruitment of other cytoskeletal proteins to this site.
Because IpaAdecreases integrin affinity for ligands,we assessed
FIGURE 3. Mapping the vinculin binding site on IpaA. A, linear schematic is
shown of IpaA and the fragments of IpaA as fusion proteins of GFP. B, the
fusion proteins were expressed in HeLa cells for 18 h, immunoprecipitated
from cell lysates using an antibody against GFP, prepared, and blotted for
vinculin as described in the legend to Fig. 1. C, REF52 cells expressing GFP-
IpaA-(1–500) or GFP-IpaA-(500 – 633) for 18 h were analyzed as described in
the legend of Fig. 1. Bar  50 m.
FIGURE 4. IpaA increases Rho activity and myosin light chain phosphoryl-
ation. Lysates from REF52 cells expressing GFP, GFP-IpaA, GFP-IpaA-(1–500)
(1–500), or GFP-IpaA-(500 – 633) (500 – 633) were harvested. A, the amount of
GTP-bound Rho was measured using a GST fusion protein containing the
Rho-binding domain of Rhotekin (RBD) that selectively binds only GTP-bound
Rho. GST-RBD precipitations were probed with a monoclonal antibody
against Rho. Rho immunoblots show Rho protein levels in the pulldowns
(Active Rho) or a sample of total cell lysates (total Rho). B, the lysates were
separated by SDS-PAGE and subjected to Western blot analysis with antibod-
ies that recognize phosphorylated myosin light chain serine 19 (MLC-P) or
total myosin light chain (MLC).
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whether it perturbs talin binding to vinculin or the integrin
cytoplasmic domain itself. We first explored coprecipitation of
talin with vinculin in immunoprecipitates from cells expressing
GFP or GFP-IpaA. In comparison with the talin recruitment to
vinculin in the GFP-expressing cells, we noticed a slight
decrease in the amount of talin recruited to vinculin in cells
expressing GFP-IpaA 18 h post-transfection (Fig. 6A). In cells
30 h post-transfection, GFP-IpaA, but not GFP alone, resulted
in a decrease in the level of talin coprecipitating with vinculin
(Fig. 6A).
We considered whether talin binding to the integrin cyto-
plasmic domain was affected under these conditions. Two pos-
sibilities exist. Talin recruitment to the intracellular domain of
integrin  subunit is lost or talin remains bound. Because the
affinity of integrins for talin is very low and hard to detect in
conventional integrin immunoprecipitates, we took advantage
of a recombinant integrin construct
that mimics four clustered integrin
cytoplasmic domains (29). His-
tagged versions of these integrin
cytoplasmic domain mimetics were
produced in bacteria, purified and
attached to nickel-nitrilotriacetic
acid beads. We found that this con-
struct readily recovered talin from
platelet extracts (data not shown)
and addition of varying concentra-
tions of GST or GST-IpaA-(500–
633) to the platelet extracts did not
interfere with talin binding (Fig.
6B). In contrast addition of even low
amounts of GST-IpaA (0.2 g) to
the extracts decreased talin recruit-
ment and high doses (2 g) of GST-
IpaA orGST-IpaA-(1–500) blocked binding of talin to the inte-
grin cytoplasmic domain (Fig. 6B). These findings suggest that
IpaA disrupts cell-matrix adhesions by interfering with the
recruitment of talin to the integrin cytoplasmic domain.
DISCUSSION
In this study we examined the mechanism for IpaA-induced
cytoskeletal rearrangements. Earlier work suggested that IpaA
binds to vinculin and induces increased recruitment of F-actin
to vinculin and depolymerization of actin stress fibers (8, 21).
Here we show that vinculin is not required for the effects of
IpaAon the actin cytoskeleton.Our data do not suggest that the
interaction of vinculin is unimportant for Shigella, but that it is
not needed for the disruption of stress fibers or cell rounding
that occur in response to IpaA. Rather we present evidence that
IpaA activates the small GTPase Rho leading to elevated myo-
sin light chain phosphorylation and increased contractility.
Furthermore, we find that IpaA decreases cell-matrix adhesion
and the mechanism for this involves preventing talin from
binding to the integrin 1 cytoplasmic domain. Together these
observations lead us to suggest that one way that IpaA induces
cytoskeletal rearrangements necessary for Shigella entry is to
coordinately regulate the activity of Rho and the disassembly of
cell-matrix adhesions.Moreover, the result of these two effects,
namely weakened adhesion and increased contractility account
for the loss of actin stress fibers and cell rounding observed in
cultured cells into which IpaA has been introduced.
At the outset of this work we were motivated to determine
how IpaA binding to vinculin induces a loss of stress fibers.
Surprisingly, we found that the loss of stress fibers and cell
rounding occur in mouse embryo fibroblasts that lack vinculin
(Fig. 2), as well as in normal cells expressing a mutant of IpaA
that is unable to bind vinculin (Fig. 3C and supplemental data).
These findings differ from earlier work indicating that vinculin
is required for the effects of IpaA (21). One difference between
our work and the earlier work is that the studies presented here
were performed using vinculin-null mouse embryo fibroblasts
and the earlier work utilized cancer cell lines that lack detecta-
ble levels of vinculin expression. It is possible that there are
some compensatory pathways that are up-regulated in the vin-
FIGURE 5. IpaA decreases integrin affinity for ligands. Thirty hours post-transfection, HeLa cells expressing
pCMV6 (Vector) or pCMV6IpaA (IpaA) were washed and lifted from tissue culture surfaces using phosphate-
buffered saline  EDTA. The cells were stained with 12G10 (A, Active Integrin) or TS216 (B, Total Integrin)
followed by a fluorescein isothiocyanate-conjugated anti-mouse secondary antibody. Positive cells were
scored using FACS analysis and plotted as percentage of the control. Parental HeLa cells were stained with
secondary antibody alone (No Ab) and used as a negative control.
FIGURE 6. IpaA prevents talin association with vinculin and integrin cyto-
plasmic domain. A, prolonged exposure to IpaA decreases talin recruitment
to vinculin. Vinculin immunoprecipitates were recovered from HeLa cells
expressing GFP or GFP-IpaA (IpaA) at short (18 h) or long (30 h) time periods
post-transfection. The immunoprecipitates were washed, separated using
SDS-PAGE, and analyzed using Western blotting with antibodies against vin-
culin or talin. B, IpaA disrupts talin recruitment to the integrin cytoplasmic
domain. 1a integrin cytoplasmic domains attached to Sepharose beads
were incubated with talin-rich human platelet extracts and either 0.2 g or
2.0 g of GST, GST-IpaA, GST-IpaA-(1–500), or GST-IpaA-(500 – 633). The
beads were washed and the resulting products were analyzed by SDS-PAGE
and Western blotting with antibodies against talin.
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culin-nullmouse embryo fibroblasts thatmay account for some
of the differences between our work and the earlier studies.
However, our observation that IpaA exerts its effects on the
actin cytoskeleton in the absence of an intact vinculin binding
site when expressed in “normal” cell lines strongly argues
against a major role for vinculin in the IpaA-mediated loss of
actin stress fibers.
These findings raise the question as to what is the relevance
of IpaA binding to vinculin at the site of Shigella entry. Previous
studies and our work here demonstrate that vinculin is readily
recruited to IpaA (Refs. 8 and 21, and Fig. 1).We considered the
possibility that vinculinmight localize IpaA to the proper locale
at the site of entry. However, this seems very unlikely because
vinculin recruitment to the site of entry is both Rho- and IpaA-
dependent (8, 10). Alternatively, vinculin binding may be
needed for some as yet to be identified functions of IpaA. For
example, IpaA shares some homology with the Salmonella
entry effector SipA, which has several biological functions. It
will be interesting to determine whether IpaA has similar activ-
ities to SipA and if these activities are affected by the interaction
of IpaA with vinculin. It is also possible that recruitment of
IpaA to vinculin affects a later step of bacterial invasion, such as
the intercellular motility of Shigella. Vinculin has been shown
to be cleaved upon Shigella entry exposingActAhomolog bind-
ing sites and increasing bacterial motility 3-fold (35). Finally,
there is some evidence that suggests that vinculin stabilizes the
maturation of small integrin-talin complexes into more stable
adhesions (36) raising the intriguing possibility that IpaA binds
vinculin to sequester it away from an integrin-containing com-
plex. If IpaA hijacks vinculin in this manner, IpaA would be
expected to promote the turnover of the adhesion structure.
Thiswould confer upon IpaA an additional level withwhich it is
able to regulate adhesion complexes and actin cytoskeletal rear-
rangements during Shigella invasion.
Rather than vinculin mediating the effects of IpaA on the
cytoskeleton, we found that IpaA activates Rho (Fig. 4). At first,
high Rho activity seemed an unlikely candidate for mediating
the effect of IpaA because elevated Rho activity triggers the
formation of stress fibers and focal adhesions. However, in sit-
uationswhen adhesion is weak, such as in IpaA-expressing cells
(Figs. 5 and 6), the increased contractility from high Rho activ-
ity would lead to cell rounding and a loss of stress fibers. This is
analogous to what happens to a cell that is rounded during
mitosis (37). How IpaA activates Rho is not known. It has no
known sequence homology to guanine nucleotide exchange
factors for members of the Rho family of GTPases or other
bacterial proteins that serve as guanine nucleotide exchange
factors suggesting that it is unlikely that IpaA acts alone as a
guanine nucleotide exchange factor. The possibility that IpaA
activates an endogenous guanine nucleotide exchange factor
for Rho or inhibits a Rho GTPase activating protein will be
investigated in future studies.
We also found that IpaA induces a loss of integrin-mediated
adhesion. Cells expressing GFP-IpaA had a lower affinity for
integrin ligands than GFP expressing cells and recruitment of
talin to the integrin cytoplasmic domain was impaired. Unlike
other bacteria, Shigellapreferentially enters polarized epithelial
cells at the basolateral pole, a region rich in 51 integrins (15),
and this effect is mimicked in cell culture where Shigella invade
more efficiently at focal adhesions (20). Hence decreased adhe-
sion at the site of Shigella entry is likely to be a late step in the
invasion process and is consistent with the observation that
IpaA facilitates entry but is not required (8).
It is striking that the Shigella Ipa proteins target both sides of
integrin-type adhesions. Thus, IpaB and IpaC bind to the extra-
cellular domain of integrins andhave been implicated in attach-
ment of the bacterium to host cells and subsequent internaliza-
tion (20). On the other hand, IpaA binds to vinculin (8), a
protein at the cytoplasmic face of integrin-mediated adhesions,
and we show here that it blocks the interaction of talin with
integrin cytoplasmic domains. The effects appear at first sight
to be antagonistic, initially promoting adhesion and then dis-
rupting it. This leads us to speculate that the bacteriummay be
exploiting host mechanisms for internalization of adhesion
complexes. Recent evidence indicates that focal adhesions
(sites of integrin engagement and clustering) are turned over by
an endocytic mechanism (38). Little is known about how inte-
grins are internalized, but it is likely that they must first be
disengaged from their cytoskeletal attachments. This would be
favored by dissociation of talin from the cytoplasmic domain.
Consequently, it is possible that a complex of IpaB and IpaC
initiate the internalization process and the inhibition of talin
binding to integrins by IpaA may promote a later step in endo-
cytosis and contribute to the uptake of bacteria.
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